BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 27866195)

  • 1. Comparison of Telbivudine and Entecavir Therapy on Nephritic Function and Drug Resistance in Patients with Hepatitis B Virus-Related Compensated Cirrhosis.
    Shen H; Ding F; Wang Z; Sun F; Yu Y; Zhou J; Xu W; Ni J; Wang J; Yang Y
    Cell Physiol Biochem; 2016; 40(1-2):370-378. PubMed ID: 27866195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of efficacy and renal safety of telbivudine and entecavir in treatment-naive elderly patients with chronic hepatitis B.
    Law ST; Lee MK; Li KK; Mok CK
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):193-8. PubMed ID: 26587867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of clinical efficacy and renal safety of telbivudine and entecavir in chronic hepatitis B patients receiving cytotoxic chemotherapy.
    Law ST; Lee MK; Lee AS; Tung Y; Li KK
    J Dig Dis; 2016 May; 17(5):325-33. PubMed ID: 27085094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of telbivudine versus entecavir in treating higher viral load chronic hepatitis B patients without cirrhosis.
    Pan HY; Pan HY; Song WY; Zheng W; Tong YX; Yang DH; Dai YN; Chen MJ; Wang MS; Huang YC; Zhang JJ; Huang HJ
    J Viral Hepat; 2017 Nov; 24 Suppl 1():29-35. PubMed ID: 29082652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil.
    Lu JJ; Liu K; Ma YJ; Wang J; Chen EQ; Tang H
    J Viral Hepat; 2013 Apr; 20 Suppl 1():40-5. PubMed ID: 23458523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of entecavir or telbivudine therapy in patients with chronic hepatitis B virus infection pre-treated with interferon compared with de novo therapy with entecavir and telbivudine.
    Cai S; Cao J; Yu T; Xia M; Peng J
    Medicine (Baltimore); 2017 Jun; 96(22):e7021. PubMed ID: 28562554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing the efficacy and clinical outcome of telbivudine and entecavir naïve patients with hepatitis B virus-related compensated cirrhosis.
    Tsai MC; Yu HC; Hung CH; Lee CM; Chiu KW; Lin MT; Tseng PL; Chang KC; Yen YH; Chen CH; Hu TH
    J Gastroenterol Hepatol; 2014 Mar; 29(3):568-75. PubMed ID: 24716215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Entecavir to Telbivudine Switch Therapy in Entecavir-Treated Patients with Undetectable Hepatitis B Viral DNA.
    Kim DH; Choi JW; Seo JH; Cho YS; Won SY; Park BK; Jeon HH; Shin SY; Lee CK
    Yonsei Med J; 2017 May; 58(3):552-556. PubMed ID: 28332360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of telbivudine and entecavir for HBeAg-positive chronic hepatitis B: a meta-analysis.
    Su QM; Ye XG
    World J Gastroenterol; 2012 Nov; 18(43):6290-301. PubMed ID: 23180951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of telbivudine and entecavir on the change of off- treatment eGFR after 3 years of treatment in non-cirrhotic chronic hepatitis B patients.
    Lin YS; Shih SC; Wang HY; Lin CC; Chang CW; Chen MJ
    BMC Gastroenterol; 2017 Jan; 17(1):22. PubMed ID: 28137301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of telbivudine compared with entecavir in hepatitis B virus-related cirrhosis: 2 year follow-up data.
    Kim HR; Yim HJ; Kang S; Suh SJ; Kim SY; Hyun JJ; Koo JS; Kim JH; Seo YS; Yeon JE; Lee SW; Byun KS; Um SH
    Liver Int; 2015 Mar; 35(3):860-9. PubMed ID: 24905912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of Lamivudine, Telbivudine, Adefovir Dipivoxil and Entecavir on decompensated hepatitis B virus-related cirrhosis.
    Wang GL; Liu Y; Qiu P; Zhou SF; Xu LF; Wen P; Wen JB; Xiao XZ
    Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):866-72. PubMed ID: 27010143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential effects of telbivudine and entecavir on renal function: a systematic review and meta-analysis.
    Wu X; Cai S; Li Z; Zheng C; Xue X; Zeng J; Peng J
    Virol J; 2016 Apr; 13():64. PubMed ID: 27062520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential Effects of Telbivudine Versus Entecavir on Renal Function in Patients With Chronic Hepatitis B Virus Receiving Glucocorticoids Therapy.
    Liu B; Shen B; Mei M; Li L; Wang X; Zhao H
    Ther Apher Dial; 2020 Feb; 24(1):56-63. PubMed ID: 31090170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telbivudine protects renal function in patients with chronic hepatitis B infection in conjunction with adefovir-based combination therapy.
    Lee M; Oh S; Lee HJ; Yeum TS; Lee JH; Yu SJ; Kim HY; Yoon JH; Lee HS; Kim YJ
    J Viral Hepat; 2014 Dec; 21(12):873-81. PubMed ID: 24351112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telbivudine versus lamivudine and entecavir for treatment-naïve decompensated hepatitis B virus-related cirrhosis.
    Yue-Meng W; Li YH; Wu HM; Yang J; Xu Y; Yang LH; Yang JH
    Clin Exp Med; 2017 May; 17(2):233-241. PubMed ID: 27094312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Effects of Telbivudine and Entecavir Treatment on Estimated Glomerular Filtration Rate in Patients with Chronic Hepatitis B.
    Lee S; Park JY; Song K; Kim DY; Kim BK; Kim SU; Ku HJ; Han KH; Ahn SH
    Gut Liver; 2015 Nov; 9(6):776-83. PubMed ID: 25963085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of telbivudine efficacy in treatment-naive patients with hepatitis B virus-related compensated and decompensated cirrhosis in 96 weeks.
    Yang X; Li J; Zhou L; Liu J; Wang J; Lu W
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):396-403. PubMed ID: 24569820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification.
    Choi JW; Kim SH; Seo JH; Cho YS; Won SY; Park BK; Jeon HH; Lee YK; Lee CK
    Yonsei Med J; 2018 May; 59(3):383-388. PubMed ID: 29611400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of efficacy and safety of 2-year telbivudine and entecavir treatment in patients with chronic hepatitis B: a match-control study.
    Tsai MC; Chen CH; Hung CH; Lee CM; Chiu KW; Wang JH; Lu SN; Tseng PL; Chang KC; Yen YH; Hu TH
    Clin Microbiol Infect; 2014 Feb; 20(2):O90-O100. PubMed ID: 23659493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.